Profilo
Mr. Harout Semerjian is a President, Chief Executive Officer & Director at Geron Corp.
He is on the Board of Directors at Geron Corp.
and Biotechnology Innovation Organization.
Mr. Semerjian was previously employed as a President, Chief Executive Officer & Director by GlycoMimetics, Inc., a President, Chief Executive Officer & Director by Immunomedics, Inc., a Chief Commercial Officer & Executive VP by Ipsen Pharma SAS, and a Chief Commercial Officer & Executive VP by Ipsen SA. He received his undergraduate degree from Lebanese American University, an MBA from Queen's University and an MBA from Cornell University.
Ultime notizie su Harout Semerjian
Posizioni attive di Harout Semerjian
| Società | Posizione | Inizio |
|---|---|---|
| GERON CORPORATION | Amministratore Delegato | 07/08/2025 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direttore/Membro del Consiglio | 01/10/2023 |
Precedenti posizioni note di Harout Semerjian
| Società | Posizione | Fine |
|---|---|---|
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Amministratore Delegato | 21/02/2025 |
| IMMUNOMEDICS, INC. | Amministratore Delegato | 27/05/2020 |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 30/04/2020 |
| IPSEN | Corporate Officer/Principal | 01/04/2020 |
Formazione di Harout Semerjian
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Immunomedics, Inc.
Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Ipsen SA
Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Queen's University
Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Health Technology |
Lebanese American University
Lebanese American University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
















